加载中
Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wound care, specifically designed to help combat antibiotic resistance. Consequently, these products empower healthcare institutions to effectively manage a broad spectrum of dermatological challenges, encompassing everything from sudden injuries and persistent wounds to general skin ailments and specific dermatoses. Global Health Solutions, Inc. was established in 2015 and maintains its headquarters in Westlake Village, California.
收盘时
US$11.11
−US$0.89 · -7.42%
盘后
US$11.37
+US$0.26 · +2.34%
10月12日 18:23 ET
盘中时间采用ET。市场数据可能有所延迟。
Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wound care, specifically designed to help combat antibiotic resistance. Consequently, these products empower healthcare institutions to effectively manage a broad spectrum of dermatological challenges, encompassing everything from sudden injuries and persistent wounds to general skin ailments and specific dermatoses. Global Health Solutions, Inc. was established in 2015 and maintains its headquarters in Westlake Village, California.
日内区间
当前US$11.11
52周区间
当前US$11.11
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
持有
估值
39
偏贵
情绪
55
多空交织
风险
81
极高风险
动量
92
强势上行
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wound care, specifically designed to help combat antibiotic resistance. Consequently, these products empower healthcare institutions to effectively manage a broad spectrum of dermatological challenges, encompassing everything from sudden injuries and persistent wounds to general skin ailments and specific dermatoses. Global Health Solutions, Inc. was established in 2015 and maintains its headquarters in Westlake Village, California.
日内区间
当前US$11.11
52周区间
当前US$11.11
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 |
|---|---|---|---|
| 研究与开发 | 26.56万 USD | 24.6万 USD | 7500 USD |
| 销售、一般及管理费用 | 559.31万 USD | 155.12万 USD | 230.06万 USD |
| 营业费用 | 585.86万 USD | 179.71万 USD | 230.81万 USD |
| 利息收入 | 2.96万 USD | 2.87万 USD | 1.59万 USD |
| 折旧和摊销 | 5.27万 USD | 4.75万 USD | 4.39万 USD |
| 营业利润 | −585.86万 USD | −179.71万 USD | −230.81万 USD |
| 净利润 | −319.41万 USD | −176.84万 USD | −229.23万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI
iShares Micro-Cap ETFIWC
EA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSMAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
